Banco Macro: Lagging Its Peers (NYSE:BMA)

ferrantraite Thesis Banco Macro (NYSE:BMA) is one of the primary traditional banks in Argentina. It has the largest branch network in the country. The deposit composition is dominated by time deposits and saving accounts. Corporate bond issuance represents 5.1 % of company liabilities. On the other hand, the bank`s loan portfolio is focused on retail…

Read More

Marc to Market September 2023 Monthly

kontekbrothers/iStock via Getty Images There is a sense of new divergence. Most economists, including the staff at the Federal Reserve, no longer think the US is recession-bound. Unprecedented in modern times, inflation has fallen sharply, and unemployment has not risen, and the economy appears to be enjoying its third consecutive quarter, and the fourth in…

Read More

Alvotech: FDA Overhang Remains, Remaining Constructive, Initiate Hold (NASDAQ:ALVO)

Matteo Colombo Investment briefing The biosimilars drug market is forecast to expand at a geometric growth rate of ~18% from 2023—2028, garnishing immense capital inflows along the way. Alvotech (NASDAQ:ALVO) is firmly positioned within the biosimilars value chain and has the potential to unlock compelling value should it successfully convert its pipeline assets. To date,…

Read More

Genuine Parts: Stable But Lacks Organic Growth (NYSE:GPC)

LSOphoto/iStock via Getty Images Genuine Parts Company (NYSE:GPC) sells replacement parts in the automotive industry. The company has achieved good growth in recent years, but as the company’s growth seems to be maintained only through frequent acquisitions instead of organic growth, I believe investors should stay cautious. The current valuation seems to reflect quite minimal…

Read More

Betting Against Costco Is Like Betting Against Apple (NASDAQ:COST)

ptasha/iStock via Getty Images The COST Investment Thesis May Never Come Cheap We previously covered Costco Wholesale Corp. (NASDAQ:COST) in June 2023, discussing its excellent prospects as inflation abated and comparable sales expanded. Thanks to the elevated interest rate environment, more consumers also flocked to COST due to its attractively priced offerings, triggering its all-time…

Read More

American Hotel Income Properties: 10.7% Yield From US Lodging (OTCMKTS:AHOTF)

PixelsEffect Steadily growing business travel demand helped the US hotel REIT sector turn in stronger operating results for the second quarter. Buoyed by strong occupancy and room rate, the sector’s same store revenue per available room (RevPAR) grew 3.8% compared to a very strong 2Q22. S&P Global Market Intelligence Surpassing pre-pandemic RevPAR metrics, however, hasn’t…

Read More

Doug Noland’s Weekly Commentary: Curious Market Action

Urupong S&P 500 futures were up 0.7% immediately following the release of Friday’s August payrolls data. Non-farm job gains of 187,000 were marginally above the 170,000 consensus estimate (with July’s gain revised 30k lower). At 0.2% (0.24%), the increase in Average Hourly Earnings was below the 0.3% forecast and July’s 0.4% – and was the…

Read More

Weekly Indicators: Consumers Are Still King

Yuri_Arcurs/iStock via Getty Images Purpose I look at the high frequency weekly indicators because while they can be very noisy, they provide a good nowcast of the economy, and will telegraph the maintenance or change in the economy well before monthly or quarterly data is available. They are also an excellent way to “mark your…

Read More

Factors And The Magnificent Seven

MarsYu By Andrew Ang, PhD Seven mega cap US-based companies – Apple (AAPL) , Microsoft (MSFT), Amazon (AMZN), Google (GOOG,GOOGL), Nvidia (NVDA), Tesla (TSLA), and META (Facebook) – have stayed top of mind for many investors this year. These companies have been dubbed the “Magnificent Seven” (not to be confused with the 1960s movie or…

Read More

Alphabet Moonshots Are Ready For Launch

Justin Sullivan By Breakingviews Alphabet (GOOG, GOOGL) is poised to welcome the autumn harvest. Ruth Porat, the web search giant’s chief financial officer and a former technology investment banker at Morgan Stanley, will move into a new role next month that includes overseeing “other bets,” an eclectic collection of experimental projects. It’s a good time…

Read More

Local Government Financing Vehicles: A Growing Risk For China’s Economy?

Igor Kutyaev Local governments have been instrumental in driving China’s remarkable economic growth over the last 30 years, in particular by providing massive public investments in critical physical and social infrastructure. Yet, amid a slowing economy and an ailing property market, debt-laden municipalities now pose a potential risk to China’s economic growth and financial stability….

Read More

UBS Cost-Cut Gains Are A Double-Edged Sword

Arnd Wiegmann By Breakingviews UBS’s acquisition of Credit Suisse (CS) looks increasingly good – maybe a little too good. Boss Sergio Ermotti plans to keep the smaller bank’s domestic franchise and reckons he can slash costs harder and faster than his predecessor, Ralph Hamers, had planned. The problem is that the cuts also increase the…

Read More

O’Reilly Automotive: Business Continues To Outperform, But Valuation Is High (NASDAQ:ORLY)

kritdarat Atsadayuttmetee/iStock via Getty Images Overview ORLY stands as a prominent player in the automotive aftermarket industry in the United States. Renowned for its wide range of automotive parts, tools, supplies, equipment, and accessories, the company caters to two distinct customer segments: do-it-yourself [DIY] and Do-It-For-Myself [DIFM]. My recommendation for O’Reilly Automotive (NASDAQ:ORLY) is a…

Read More

Nordstrom Stock’s Turnaround Is Around The Corner (NYSE:JWN)

Sundry Photography/iStock Editorial via Getty Images Investment Thesis Nordstrom (NYSE:JWN) has undergone significant structural changes in its business model recently. We view these structural changes as a pivotal catalyst for Nordstrom’s stock performance as they enabled Nordstrom to achieve profitable growth. These structural changes include improving rack performance, increasing inventory productivity and optimizing supply chain…

Read More

Durable Goods Vs. PMI… Something Is Amiss

Vitalij Sova Manufacturers’ New Orders for Durable Goods and the PMI (Purchasing Managers’ Index) for manufacturers were reported last week. Durable Goods Orders vs. PMI compares these two series monthly from Feb 1982. The rule of thumb which has been repeated many times is that when the PMI falls below 50, it forecasts recessions. This…

Read More

Supernus: Sales Stretching Higher, But Not Reflected In Economic Leverage (NASDAQ:SUPN)

ozgurdonmaz Investment Briefing Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) is a biopharmaceutical company that specializes in developing and commercializing treatments for central nervous system (“CNS”) disorders. The company’s neuroscience portfolio comprises a range of approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (“ADHD”), and hypomobility in Parkinson’s Disease (“PD”). It currently has 8 commercial products in the…

Read More

Is There Still A Bull Case For Bonds?

Hemera Technologies/PHOTOS.com>> via Getty Images Bonds from a growth and inflation perspective For those who have been bullish bonds and calling for a rally throughout 2023, it has been on the back of falling growth and waning inflation such thesis have been based. By simply looking at the traditional relationship between yields and the business…

Read More

Chewy Stock: I Am Buying The Drop Aggressively (NYSE:CHWY)

Liudmila Chernetska/iStock via Getty Images Chewy (NYSE:CHWY) reported better than expected results for the second-quarter on Wednesday that showed not only a significant EPS beat, but also double-digit net revenue growth and expanding gross margins. The retailer’s shares, however, have widely underperformed in the last year, chiefly because of concerns about slowing customer growth and…

Read More

CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch (NASDAQ:GDTC)

Design Cells/iStock via Getty Images CytoMed Therapeutics (NASDAQ:GDTC) CytoMed Therapeutics (GDCT, or the Company), a Singapore-based biotechnology company trading on the NASDAQ, is developing multiple gamma delta chimeric antigen receptor T-cell (“γδ CAR-T”) therapeutics for the treatment of cancer. The Company is one of many who are trying to exploit the body’s immune system to…

Read More

Raiffeisen Bank International: Recent Developments Support The Bear Case (OTCMKTS:RAIFF)

SlavkoSereda/iStock Editorial via Getty Images In a previous article discussing Raiffeisen Bank International AG (OTCPK:RAIFF; OTCPK:RAIFY), I identified two main risks: the bank’s significant reliance on its Russian subsidiary and its exposure to Signa Group. There have been further negative developments both at Signa (kindly note, that following, unless otherwise stated, “Signa” refers to the…

Read More